Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (610) clinical trials

This study will assess the effectiveness of pimavanserin when given along with a selective serotonin reuptake inhibitor/selective norepinephrine reuptake inhibitor (SSRI/SNRI) for depression in adults with Parkinson’s disease.

Phase

This is a multi-site, placebo-controlled, double-blind, randomized-withdrawal study evaluating the durability of clinical benefit of a study drug for patients with symptomatic neurogenic orthostatic hypotension. This study has a duration of up to 36 weeks, consisting of 5 periods:  Screening Period: up to 4 weeks duration;  Open-Label Titration Period (Titration ...

Phase

People with Parkinson's Disease Dementia are asked to participate in a research study being conducted by New York University School of Medicine.

Effectiveness of study drug  LY3154207 on cognition and memory in person's with Mild to Moderate Parkinson's Disease Dementia (PDD)  

Phase

This is a randomized placebo-controlled trial in individuals with Parkinson's disease dementia to evaluate the safety and efficacy of three doses of a study drug in participants with mild-to-moderate Parkinson's disease dementia treated for 12 weeks.  

Phase

Subjects stable on L-Dopa and oral ropinirole will have their ropinirole replaced with the Ropinirole Implant(s). The Ropinirole Implant was designed using the ProNeura™ implant technology where the implant is inserted under the skin. This study will measure how much ropinirole is released in the blood during 3 months of dosing, and evaluate ...

Phase

A clinical research study is underway, evaluating an investigational study drug for adults with Parkinson's Disease who are experiencing a decline in memory and thinking.

Phase

Suffer from Parkinson’s-related LID? Learn more about a clinical trial for levodopa-induced dyskinesia. Right now, the gLIDe clinical research study is enrolling adults with Parkinson’s Disease who have levodopa-induced dyskinesia (involuntary movements). Researchers are testing an investigational drug to learn whether it may relieve this effect in these patients. People ...

Phase N/A

Join the Fight Against Parkinson's Disease Wake Research is looking for participants for a clinical research study of an investigational medication for people with Parkinson's disease and mild cognitive impairment (MCI) or dementia.  

Phase N/A

A 24-week, prospective, multi-center, open-label, Phase 3 study in L-Dopa responsive PD patients with motor fluctuations ("OFF" episodes), designed to evaluate the long-term safety, tolerability and efficacy of APL-130277.  

Phase